Abstract:Background and purpose: Mutations in the PLA2G6 gene are causative of PLA2G6-associated neurodegeneration (PLAN), a spectrum of neurodegenerative conditions including infantile, childhood and adult onset forms. Methods: Seventeen North African patients with a clinical suspicion of infantile-onset PLAN underwent clinical, neurophysiological and neuroimaging examinations, and PLA2G6 sequencing. Haplotype analysis was performed to date the identified founder mutation. Results: All patients carried biallelic mutations in PLA2G6. Sixteen children had the commonest form of infantile-onset PLAN, with early onset of psychomotor regression, hypotonia, pyramidal and cerebellar signs, and abnormal ocular movements. The phenotype was highly homogeneous, with rapid development of severe spastic tetraparesis, cognitive impairment and optic atrophy. Neuroimaging showed cerebellar atrophy and claval hypertrophy to be the commonest and earliest signs, whilst cerebellar cortex hyperintensity and pallidal iron deposition were later findings. Motor or sensory-motor neuropathy and electroencephalogram fast rhythms were also frequent. Nine patients from six families shared the same founder mutation (p.V691del) which probably arose by the late seventeenth century. Only one patient fitted the diagnosis of the much rarer childhood-onset PLAN. Despite the early onset (18 months), clinical progression was slower, with behavioral disturbances and dystonia. Typical features of infantile-onset PLAN such as hypotonia, nystagmus/strabismus, optic atrophy, electroencephalogram fast rhythms and motor neuropathy were absent. Cerebellar atrophy, claval hypertrophy and pallidal hypointensity were evident at brain magnetic resonance imaging. This patient carried a missense variant predicted to be less deleterious. Conclusions: The PLAN-associated phenotypes and the challenges of diagnosing the childhood-onset form are delineated, and a common North African founder mutation is identifed.

Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration.

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

PLA2G6-Associated Neurodegeneration (PLAN): Review of Clinical Phenotypes and Genotypes

Novel PLA2G6 Pathogenic Variants in Chinese Patients With PLA2G6-Associated Neurodegeneration

Clinical Characterization and Founder Effect Analysis in Chinese Patients with Phospholipase A2-Associated Neurodegeneration

Novel Compound Heterozygous of PARKIN Causes Early-Onset Parkinson's Disease

A systematic analysis of genotype–phenotype associations with PLA2G6

The Clinical, Radiological and Genetic Spectrum of PLA2G6-Associated Neurodegeneration: An Experience From a Tertiary Center

Follow-Up Study of 25 Chinese Children with Pla2g6-Associated Neurodegeneration

Early-Onset Parkinson's Disease Caused by PLA2G6 Compound Heterozygous Mutation, a Case Report and Literature Review

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study

Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging

Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort

A novel variant of PLA2G6 gene related early-onset parkinsonism: a case report and literature review

An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration

Neurodegeneration associated with genetic defects in phospholipase A(2)

Pla2g6 Gene Mutation in Autosomal Recessive Early-Onset Parkinsonism in A Chinese Cohort

Identification of PLA2G6 Variants in a Chinese Patient with Parkinson's Disease

Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.

Comprehensive variant analysis of phospholipase A2 superfamily genes in large Chinese Parkinson' s disease cohorts